Ferulic acid ethyl ester protects neurons against amyloid β-peptide(1-42)-induced oxidative stress and neurotoxicity: Relationship to antioxidant activity

Journal of Neurochemistry

Volumn 92, Issue 4, 2005, Pages 749-758

  Sultana, Rukhsana ^a   Ravagna, Agrippino ^c   Mohmmad Abdul, Hafiz ^a   Calabrese, Vittorio ^c   Butterfield, D Allan ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF CATANIA   (Italy)

Author keywords

Amyloid peptide; Ferulic acid ethyl ester; Heat shock protein; Heme oxygenase 1; Inducible nitric oxide synthase; Oxidative stress

Indexed keywords

3 NITROTYROSINE; 4 HYDROXYNONENAL; AMYLOID BETA PROTEIN[1-42]; CARBONYL DERIVATIVE; ESTER DERIVATIVE; FERULIC ACID; HEAT SHOCK PROTEIN 72; HEME OXYGENASE 1; INDUCIBLE NITRIC OXIDE SYNTHASE; RADICAL; REACTIVE OXYGEN METABOLITE; SCAVENGER;

ALZHEIMER DISEASE; ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN NERVE CELL; CELL CULTURE; CELL VIABILITY; ENZYME INDUCTION; HIPPOCAMPUS; LIPID PEROXIDATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

AMYLOID BETA-PROTEIN; ANIMALS; ANTIOXIDANTS; CAFFEIC ACIDS; CELLS, CULTURED; CEREBRAL CORTEX; NEURONS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 13644265462     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2004.02899.x     Document Type: Article

References (76)

1. Aksenov M. Y., Aksenova M. V., Butterfield D. A., Geddes J. W. and Markesbery W. R. (2001) Protein oxidation in the brain in Alzheimer's disease. Neuroscience 103, 373-383.
2. Behl C. (1997) Amyloid beta-protein toxicity and oxidative stress in Alzheimer's disease. Cell Tissue Res. 290, 471-480.
3. Braak H. and Braak E. (1997) Staging of Alzheimer-related cortical destruction. Int. Psychogeriatr. 9, 257-266.
4. Bradford M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
5. Bredt D. S. (1999) Endogenous nitric oxide synthesis: biological functions and pathophysiology. Free Radic. Res. 31, 577-596.
6. Butterfield D. A. (1997) beta-Amyloid-associated free radical oxidative stress and neurotoxicity: implications for Alzheimer's disease. Chem. Res. Toxicol. 10, 495-506.
7. Butterfield D. A. (2002) Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review. Free Radic. Res. 36, 1307-1313.
8. Butterfield D. A. and Kanski J. (2001) Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins. Mech. Ageing Dev. 122, 945-962.
9. Butterfield D. A. and Lauderback C. M. (2002) Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid β-peptide-associated free radical oxidative stress. Free Rad. Biol. Med. 32, 1050-1060.
10. Butterfield D. A. and Stadtman E. R. (1997) Protein oxidation processes in aging brain. Adv. Cell Aging Gerontol. 2, 161-191.
11. Butterfield D. A., Yatin S. M., Varadarajan. S. and Koppal. T. (1999) Amyloid β-peptide-associated free radical oxidative stress, neurotoxicity, and Alzhemeir's disease. Meth. Enzymol. 309, 746-768.
12. Butterfield D. A., Drake J., Pocernich C. and Castegna A. (2001) Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide. Trends Mol. Med. 7, 548-554.
13. Butterfield D. A., Castegna A., Lauderback C. M. and Drake J. (2002a) Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death. Neurobiol. Aging 23, 655-664.
14. Butterfield D., Castegna A., Pocernich C., Drake J., Scapagnini G. and Calabrese V. (2002b) Nutritional approaches to combat oxidative stress in Alzheimer's disease. J. Nutr. Biochem. 13, 444.
15. Calabrese V., Scapagnini G., Ravagna A., Fariello R. G., Giuffrida Stella A. M. and Abraham N. G. (2002) Regional distribution of heme oxygenase, HSP70, and glutathione in brain: relevance for endogenous oxidant/antioxidant balance and stress tolerance. J. Neurosci. Res. 68, 65-75.
16. Calabrese V., Scapagnini G., Colombrita C., Ravagna A., Pennisi G., Giuffrida Stella A. M., Galli F. and Butterfield D. A. (2003) Redox regulation of heat shock protein expression in aging and neurodegenerative disorders associated with oxidative stress: a nutritional approach. Amino Acids 25, 437-444.
17. Castegna A., Aksenov M., Aksenova M., Thongboonkerd V., Klein J. B., Pierce W. M., Booze R., Markesbery W. R. and Butterfield D. A. (2002a) Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1. Free Radic. Biol. Med. 33, 562-571.
18. Castegna A., Aksenov M., Thongboonkerd V., Klein J. B., Pierce W. M., Booze R., Markesbery W. R. and Butterfield D. A. (2002b) Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71. J. Neurochem. 82, 1524-1532.
19. Castegna A., Thongboonkerd V., Klein J. B., Lynn B., Markesbery W. R. and Butterfield D. A. (2003) Proteomic identification of nitrated proteins in Alzheimer's disease brain. J. Neurochem. 85, 1394-1401.
20. Cotman C. W. (1998) Apoptosis decision cascades and neuronal degeneration in Alzheimer's disease. Neurobiol. Aging 19, S29-S32.
21. Drake J., Kanski J., Varadarajan S., Tsoras M. and Butterfield D. A. (2002) Elevation of brain glutathione by gamma-glutamylcysteine ethyl ester protects against peroxynitrite-induced oxidative stress. J. Neurosci. Res. 68, 776-784.
22. Drake J., Sultana R., Aksenova M., Calabrese V. and Butterfield D. A. (2003a) Elevation of mitochondrial glutathione by gamma-glutamylcysteine ethyl ester protects mitochondria against peroxynitrite-induced oxidative stress. J. Neurosci. Res. 74, 917-927.
23. Drake J., Link C. D. and Butterfield D. A. (2003b) Oxidative stress precedes fibrillar deposition of Alzheimer's disease amyloid beta-peptide (1-42) in a transgenic Caenorhabditis elegans model. Neurobiol. Aging 24, 415-420.
24. Esterbauer H., Schaur R. J. and Zollner H. (1991) Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde, and related aldehydes. Free Rad. Biol. Med. 11, 81-128.
25. Gridley K. E., Green P. S. and Simpkins J. W. (1998) A novel, synergistic interaction between 17 beta-estradiol and glutathione in the protection of neurons against beta-amyloid 25-35-induced toxicity in vitro. Mol. Pharmacol. 54, 874-880.
26. Halliwell B. (2001) Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging 18, 685-716.
27. Hensley K., Hall N., Subramaniam R. et al. (1995) Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J. Neurochem. 65, 2146-2156.
28. Hensley K., Maidt M. L., Yu Z., Sang H., Markesbery W. R. and Floyd R. A. (1998) Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation. J. Neurosci. 18, 8126-8132.
29. Kanski J., Aksenova M., Stoyanova A. and Butterfield D. A. (2002) Ferulic acid antioxidant protection against hydroxyl and peroxyl radical oxidation in synaptosomal and neuronal cell culture systems in vitro: structure-activity studies. J. Nutr. Biochem. 13, 273-281.
30. Kikuzaki H., Hisamoto M., Hirose K., Akiyama K. and Taniguchi H. (2002) Antioxidant properties of ferulic acid and its related compounds. J. Agric. Food Chem. 50, 2161-2168.
31. Kim H. S., Cho J. Y., Kim D. H., Yan J. J., Lee H. K., Suh H. W. and Song D. K. (2004) Inhibitory effects of long-term administration of ferulic acid on microglial activation induced by intracerebroventricular injection of beta-amyloid peptide(1-42) in mice. Biol. Pharm. Bull. 27, 120.
32. Koh J. Y., Yang L. L. and Cotman C. W. (1990) Beta-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res. 533, 315-320.
33. Koppal T., Drake J., Yatin S., Jordan B., Varadarajan S., Bettenhausen L. and Butterfield D. A. (1999) Peroxynitrite-induced alterations in synaptosomal membrane proteins: insight into oxidative stress in Alzheimer's disease. J. Neurochem. 72, 310-317.
34. Lambert M. P., Barlow A. K., Chromy B. A. et al. (1998) Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc. Natl Acad. Sci. USA 95, 6448-6453.
35. Lauderback C. M., Hackett J. M., Huang F. F., Keller J. N., Szweda L. I., Markesbery W. R. and Butterfield D. A. (2001) The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Abeta1-42. J. Neurochem. 78, 413-416.
36. Le W. D., Xie W. J. and Appel S. H. (1999) Protective role of heme oxygenase-1 in oxidative stress-induced neuronal injury. J. Neurosci. Res. 56, 652-658.
37. Lim G. P., Chu T., Yang F., Beech W., Frautschy S. A. and Cole G. M. (2001) The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimers transgenic mouse. J. Neurosci. 21, 8370-8377.
38. Lovell M. A., Xie C. and Markesbery W. R. (2001) Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures. Neurobiol. Aging 22, 187-194.
39. Lowe J., Landon M., Pike I., Spendlove I., McDermott H. and Mayer R. J. (1990) Dementia with beta-amyloid deposition: involvement of alpha B-crystallin supports two main diseases. Lancet 336, 515-516.
40. Magrane J., Smith R. C., Walsh K. and Querfurth H. W. (2004) Heat shock protein 70 participates in the neuroprotective response to intracellularly expressed beta-amyloid in neurons. J. Neurosci. 24, 1700-1706.
41. Markesbery W. R. (1997) Oxidative stress hypothesis in Alzheimer's disease. Free Radic. Biol. Med. 23, 134-147.
42. Markesbery W. R. and Carney J. H. (1999) Oxidative alterations in Alzheimer's disease. Brain Pathol. 9, 133-146.
43. Markesbery W. R. and Lovell M. A. (1998) Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neurobiol. Aging 19, 133-136.
44. Masliah E. (1998) Mechanisms of synaptic pathology in Alzheimer's disease. J. Neural Transm. 53, 147-158.
45. Mattson M. P. (1997) Advances fuel Alzheimer's conundrum. Nat. Genet. 17, 254-256.
46. Mattson M. P. and Mattson E. P. (2002) Amyloid peptide enhances nail rusting: novel insight into mechanisms of aging and Alzheimer's disease. Ageing Res. Rev. 1, 327-330.
47. McIntosh L. J., Trush M. A. and Troncoso J. C. (1997) Increased susceptibility of Alzheimer's disease temporal cortex to oxygen free radical-mediated processes. Free Radic. Biol. Med. 23, 183-190.
48. Namba Y., Tomonaga M., Ohtsuka K., Oda M. and Ikeda K. (1991) HSP 70 is associated with abnormal cytoplasmic inclusions characteristic of neurodegenerative diseases. No To Shinkei. 43, 57-60.
49. Nitsch R. M., Blusztajn J. K., Pittas A. G., Slack B. E., Growdon J. H. and Wurtman R. J. (1992) Evidence for a membrane defect in Alzheimer disease brain. Proc. Natl Acad. Sci. USA 89, 1671-1675.
50. Ogiwara T., Satoh K., Kadoma Y., Murakami Y., Unten S., Atsumi T., Sakagami H. and Fujisawa S. (2002) Radical scavenging activity and cytotoxicity of feralic acid. Anticancer Res. 22, 2711-2717.
51. Omar R. A., Chyan Y. J., Andorn A. C., Poeggeler B., Robakis N. K. and Pappolla M. A. (1999) Increased expression but reduced activity of antioxidant enzymes in Alzheimer's disease. J. Alzheimers Dis. 1, 139-145.
52. Park C. S., Krishna G., Ahn M. S., Kang J. H., Chung W. G., Kim D. J., Hwang H. K., Lee J. N., Paik S. G. and Cha Y. N. (2000) Differential and constitutive expression of neuronal, inducible, and endothelial nitric oxide synthase mRNAs and proteins in pathologically normal human tissues. Nitric Oxide 4, 459-471.
53. Perez N., Sugar J., Charya S., Johnson G., Merril C., Bierer L., Perl D., Haroutunian V. and Wallace W. (1991) Increased synthesis and accumulation of heat shock 70 proteins in Alzheimer's disease. Brain Res. Mol. Brain Res. 11, 249-254.
54. Picklo M. J., Montine T. J., Amarnath V. and Neely M. D. (2002) Carbonyl toxicology and Alzheimer's disease. Toxicol. Appl. Pharmacol. 184, 187-197.
55. Poon H. F., Calabrese V., Scapagnini G. and Butterfield D. A. (2004) Free radicals: key to brain aging and heme oxygenase as a cellular response to oxidative stress. J. Gerontol. A Biol. Sci. Med. Sci. 59, 478-493.
56. Premkumar D. R., Smith M. A., Richey P. L., Petersen R. B., Castellani R., Kutty R. K., Wiggert B., Perry G. and Kalaria R. N. (1995) Induction of heme oxygenase-1 mRNA and protein in neocortex and cerebral vessels in Alzheimer's disease. J. Neurochem. 65, 1399-1402.
57. Renkawek K., Stege G. J. and Bosman G. J. (1999) Dementia, gliosis and expression of the small heat shock proteins hsp27 and alpha B-crystallin in Parkinson's disease. Neuroreport 10, 2273-2276.
58. Scapagnini G., Foresti R., Calabrese V., Giuffrida Stella A. M., Green C. J. and Motterlini R. (2002) Caffeic acid phenethyl ester and curcumin: a novel class of heme oxygenase-1 inducers. Mol. Pharmacol. 61, 554-561.
59. Scapagnini G., Butterfield D. A., Colombrita C., Sultana R., Pascale A. and Calabrese V. (2004) Ethyl ferulate, a lipophilic polyphenol, induces HO-1 and protects rat neurons against oxidative stress. Antioxid. Redox Signal. 6, 811-818.
60. Schipper H. M., Cisse S. and Stopa E. G. (1995) Expression of heme oxygenase-1 in the senescent and Alzheimer-diseased brain. Ann. Neurol. 37, 758-768.
61. Selkoe D. J. (1994) Alzheimer's disease: a central role for amyloid. J. Neuropathol. Exp. Neurol. 53, 438-447.
62. Sinha S. and Lieberburg I. (1999) Cellular mechanisms of beta-amyloid production and secretion. Proc. Natl Acad. Sci. USA 96, 11 049-11 053 .
63. Smith M. A., Richey Harris P. L., Sayre L. M., Beckman J. S. and Perry G. (1997) Widespread peroxynitrite-mediated damage in Alzheimer's disease. J. Neurosci. 17, 2653-2657.
64. Smith M. A., Rottkamp C. A., Nunomura A., Raina A. K. and Perry G. (2000) Oxidative stress in Alzheimer's disease. Biochim. Biophys. Acta 26, 139-144.
65. Subbarao K. V., Richardson J. S. and Ang L. C. (1990) Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro. J. Neurochem. 55, 342-345.
66. Sultana R., Newman S., Abdul-Mohmmad H., Keller J. N. and Butterfield D. A. (2004) Protective effect of the xanthate, D609, on Alzheimer's amyloid beta-peptide (1-42)-induced oxidative stress in primary neuronal cells. Free Radic. Res. 38, 449-458.
67. Svennerholm L. and Gottfries C. G. (1994) Membrane lipids, selectively diminished in Alzheimer brains, suggest synapse loss as a primary event in early-onset form (type I) and demyelination in late-onset form (type II). J. Neurochem. 62, 1039-1047.
68. Takata K., Kitamura Y., Kakimura J., Shibagaki K., Taniguchi T., Gebicke-Haerter P. J., Smith M. A., Perry G. and Shimohama S. (2002) Possible protective mechanisms of heme oxygenase-1 in the brain. Ann. NY Acad. Sci. 977, 501-506.
69. Varadarajan S., Yatin S., Aksenova M. and Butterfield D. A. (2000) Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity. J. Struct. Biol. 130, 184-208.
70. Walsh D. M., Hartley D. M., Kusumoto Y. et al. (1999) Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. J. Biol. Chem. 274, 25 945-25 952.
71. Wang Q., Xiong L. Z. and Chen S. Y. (2003) Effect of sodium ferulate on activation of extracellular signal regulated kinase after cerebral ischemia/reperfusion injury in rats. Zhongguo Zhong Xi Yi Jie He Za Zhi. 23, 918-921.
72. Yankner B. A. (2000) The pathogenesis of Alzheimer's disease. Is amyloid beta-protein the beginning or the end? Ann. NY Acad. Sci. 924, 26-28.
73. Yatin S. M., Varadarajan S., Link C. D. and Butterfield D. A. (1999) In vitro and in vivo oxidative stress associated with Alzheimer's amyloidbeta-peptide (1-42). Neurobiol. Aging 20, 325-330.
74. Yatin S. M., Varadarajan S. and Butterfield D. A. (2000) Vitamin E prevents Alzheimer's amyloid beta-peptide (1-42)-induced neuronal protein oxidation and reactive oxygen species production. J. Alzheimers Dis. 2, 123-131.
75. Yoo B. C., Seidl R., Cairns N. and Lubec G. (1999) Heat-shock protein 70 levels in brain of patients with Down syndrome and Alzheimer's disease. J. Neural Transm. Suppl. 57, 315-322.
76. Yu H., Hong J. and Wu D. (1999) Effect of sodium ferulate on proliferation of rabbit aortic smooth muscle cells induced by oxidized LDL. Zhongguo Zhong Yao Za Zhi. 24, 365-366.